Artículos por temáticas

Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential

Al Amin M, Dehbia Z, Nafady MH, Zehravi M, Kumar KP, Haque MA, Baig MS, Farhana A, Khan SL, Afroz T, Koula D, Tutone M, Nainu F, Ahmad I, Emran TB.

Mol Cell Biochem. 2025 Jan;480(1):43-73. doi: 10.1007/s11010-023-04922-w. Epub 2024 Apr 3.

Precision diagnosis of cognitive impairment due to Alzheimer's disease for therapeutic interventions

Knopman DS.

Alzheimers Dement. 2025 Jan;21(1):e14043. doi: 10.1002/alz.14043. Epub 2024 Dec 24.

A thematic review on therapeutic toys and games for the elderly with Alzheimer's disease

You D, Hasley Bin Ramli S, Ibrahim R, Hibatullah Bin Romli M, Li Z, Chu Q, Yu X.

Disabil Rehabil Assist Technol. 2025 Jan;20(1):1-13. doi: 10.1080/17483107.2023.2299713. Epub 2024 Feb 1.

Comparison of the efficacy of updated drugs for the treatment on the improvement of cognitive function in patients with Alzheimer 's disease: A systematic review and network meta- analysis

Cao W, Zhu B, Liu Z, Jia X, Zhao H, Gu N, Chang H, Xi J, Li R, Guo K, Shen J, Ding L, Sun F, Di Z.

Neuroscience. 2025 Jan 26;565:29-39. doi: 10.1016/j.neuroscience.2024.11.029. Epub 2024 Nov 15.

The complex relationship between gut microbiota and Alzheimer's disease: A systematic review

Zhou XP, Sun LB, Liu WH, Zhu WM, Li LC, Song XY, Xing JP, Gao SH.

Ageing Res Rev. 2025 Feb;104:102637. doi: 10.1016/j.arr.2024.102637. Epub 2024 Dec 9.

Efficacy and molecular mechanisms of hesperidin in mitigating Alzheimer's disease: A systematic review

Han X, Zhang Y, Zhang L, Zhuang Y, Wang Y.

Eur J Med Chem. 2025 Feb 5;283:117144. doi: 10.1016/j.ejmech.2024.117144. Epub 2024 Dec 4.

Smoking Impacts Alzheimer's Disease Progression Through Oral Microbiota Modulation

Dai X, Liang R, Dai M, Li X, Zhao W.

Mol Neurobiol. 2025 Jan;62(1):19-44. doi: 10.1007/s12035-024-04241-1. Epub 2024 May 25.

Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease

Grill JD, Tam S, Thai G, Vides B, Pierce AL, Green K, Gillen DL, Teng E, Kremen S, Beigi M, Rissman RA, Léger GC, Balasubramanian A, Revta C, Morrison R, Jennings R, Pa J, Zhang J, Jin S, Messer K, Fe

Neurology. 2025 Jan 14;104(1):e210152. doi: 10.1212/WNL.0000000000210152. Epub 2024 Dec 13.

From Lab Bench to Hope: Emerging Gene Therapies in Clinical Trials for Alzheimer's Disease

Ortega A, Chernicki B, Ou G, Parmar MS.

Mol Neurobiol. 2025 Jan;62(1):1112-1135. doi: 10.1007/s12035-024-04285-3. Epub 2024 Jul 3.

The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease

Maki Y, Ubuka T, Yamane Y.

J Alzheimers Dis. 2025 Jan;103(2):358-360. doi: 10.1177/13872877241301806. Epub 2024 Dec 5.

The Neuroprotective Effect of Rooibos Herbal Tea Against Alzheimer's Disease: A Review

Chipofya E, Docrat TF, Marnewick JL.

Mol Nutr Food Res. 2025 Jan;69(1):e202400670. doi: 10.1002/mnfr.202400670. Epub 2024 Dec 19.

Systematic review and meta-analysis of repetitive transcranial magnetic stimulation (rTMS) for activities of daily living in Alzheimer's disease

Hou Y, Liu F, Lin N, Gao S.

Neurol Sci. 2025 Jan;46(1):63-77. doi: 10.1007/s10072-024-07709-z. Epub 2024 Jul 23.

Optimal dose and type of non-pharmacological treatments to improve cognitive function in people with Alzheimer's disease: a systematic review and network meta-analysis

Dou J, Zhang H, Fu X, Yang Y, Gao X.

Aging Ment Health. 2025 Feb;29(2):228-237. doi: 10.1080/13607863.2024.2379427. Epub 2024 Jul 19.

Clinical use of biomarkers in the era of Alzheimer's disease treatments

VandeVrede L, Schindler SE.

Alzheimers Dement. 2025 Jan;21(1):e14201. doi: 10.1002/alz.14201. Epub 2024 Dec 30.

Advances in Alzheimer's disease control approaches via carbon nanotubes

Cai J, Li B, Zhang J, Feng G, Liu Y, Fan H, Zheng B.

Nanomedicine (Lond). 2025 Jan;20(1):63-77. doi: 10.1080/17435889.2024.2432855. Epub 2024 Nov 28.